IBDEI10E ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47673,0)
 ;;=M86.071^^139^1991^2
 ;;^UTILITY(U,$J,358.3,47673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47673,1,3,0)
 ;;=3^Acute hematogenous osteomyelitis, rt ankl & ft
 ;;^UTILITY(U,$J,358.3,47673,1,4,0)
 ;;=4^M86.071
 ;;^UTILITY(U,$J,358.3,47673,2)
 ;;=^5014516
 ;;^UTILITY(U,$J,358.3,47674,0)
 ;;=M86.072^^139^1991^1
 ;;^UTILITY(U,$J,358.3,47674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47674,1,3,0)
 ;;=3^Acute hematogenous osteomyelitis, lft ankl & ft
 ;;^UTILITY(U,$J,358.3,47674,1,4,0)
 ;;=4^M86.072
 ;;^UTILITY(U,$J,358.3,47674,2)
 ;;=^5014517
 ;;^UTILITY(U,$J,358.3,47675,0)
 ;;=M86.171^^139^1991^4
 ;;^UTILITY(U,$J,358.3,47675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47675,1,3,0)
 ;;=3^Acute osteomyelitis, rt ankl & ft, oth
 ;;^UTILITY(U,$J,358.3,47675,1,4,0)
 ;;=4^M86.171
 ;;^UTILITY(U,$J,358.3,47675,2)
 ;;=^5014530
 ;;^UTILITY(U,$J,358.3,47676,0)
 ;;=M86.172^^139^1991^3
 ;;^UTILITY(U,$J,358.3,47676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47676,1,3,0)
 ;;=3^Acute osteomyelitis, lft ankl & ft, oth
 ;;^UTILITY(U,$J,358.3,47676,1,4,0)
 ;;=4^M86.172
 ;;^UTILITY(U,$J,358.3,47676,2)
 ;;=^5014531
 ;;^UTILITY(U,$J,358.3,47677,0)
 ;;=M86.271^^139^1991^31
 ;;^UTILITY(U,$J,358.3,47677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47677,1,3,0)
 ;;=3^Subacute osteomyelitis, rt ankl & ft
 ;;^UTILITY(U,$J,358.3,47677,1,4,0)
 ;;=4^M86.271
 ;;^UTILITY(U,$J,358.3,47677,2)
 ;;=^5014554
 ;;^UTILITY(U,$J,358.3,47678,0)
 ;;=M86.571^^139^1991^6
 ;;^UTILITY(U,$J,358.3,47678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47678,1,3,0)
 ;;=3^Chronic hematogenous osteomyel, rt ankl & ft, oth
 ;;^UTILITY(U,$J,358.3,47678,1,4,0)
 ;;=4^M86.571
 ;;^UTILITY(U,$J,358.3,47678,2)
 ;;=^5014626
 ;;^UTILITY(U,$J,358.3,47679,0)
 ;;=M86.572^^139^1991^5
 ;;^UTILITY(U,$J,358.3,47679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47679,1,3,0)
 ;;=3^Chronic hematogenous osteomyel, lft ankl & ft, oth
 ;;^UTILITY(U,$J,358.3,47679,1,4,0)
 ;;=4^M86.572
 ;;^UTILITY(U,$J,358.3,47679,2)
 ;;=^5014627
 ;;^UTILITY(U,$J,358.3,47680,0)
 ;;=M86.671^^139^1991^10
 ;;^UTILITY(U,$J,358.3,47680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47680,1,3,0)
 ;;=3^Chronic osteomyelitis, rt ankl & ft, oth
 ;;^UTILITY(U,$J,358.3,47680,1,4,0)
 ;;=4^M86.671
 ;;^UTILITY(U,$J,358.3,47680,2)
 ;;=^5014641
 ;;^UTILITY(U,$J,358.3,47681,0)
 ;;=M86.672^^139^1991^9
 ;;^UTILITY(U,$J,358.3,47681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47681,1,3,0)
 ;;=3^Chronic osteomyelitis, lft ankl & ft, oth
 ;;^UTILITY(U,$J,358.3,47681,1,4,0)
 ;;=4^M86.672
 ;;^UTILITY(U,$J,358.3,47681,2)
 ;;=^5014642
 ;;^UTILITY(U,$J,358.3,47682,0)
 ;;=M86.8X7^^139^1991^21
 ;;^UTILITY(U,$J,358.3,47682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47682,1,3,0)
 ;;=3^Osteomyelitis, ankl & ft, oth
 ;;^UTILITY(U,$J,358.3,47682,1,4,0)
 ;;=4^M86.8X7
 ;;^UTILITY(U,$J,358.3,47682,2)
 ;;=^5014653
 ;;^UTILITY(U,$J,358.3,47683,0)
 ;;=M86.371^^139^1991^8
 ;;^UTILITY(U,$J,358.3,47683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47683,1,3,0)
 ;;=3^Chronic multifoc osteomyel, rt ankl & ft
 ;;^UTILITY(U,$J,358.3,47683,1,4,0)
 ;;=4^M86.371
 ;;^UTILITY(U,$J,358.3,47683,2)
 ;;=^5014578
 ;;^UTILITY(U,$J,358.3,47684,0)
 ;;=M86.372^^139^1991^7
 ;;^UTILITY(U,$J,358.3,47684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47684,1,3,0)
 ;;=3^Chronic multifoc osteomyel, lft ankl & ft
 ;;^UTILITY(U,$J,358.3,47684,1,4,0)
 ;;=4^M86.372
 ;;^UTILITY(U,$J,358.3,47684,2)
 ;;=^5014579
 ;;^UTILITY(U,$J,358.3,47685,0)
 ;;=M92.71^^139^1991^11
 ;;^UTILITY(U,$J,358.3,47685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47685,1,3,0)
 ;;=3^Juvenile osteochondrosis of metatarsus, rt ft
 ;;^UTILITY(U,$J,358.3,47685,1,4,0)
 ;;=4^M92.71
 ;;^UTILITY(U,$J,358.3,47685,2)
 ;;=^5015239
 ;;^UTILITY(U,$J,358.3,47686,0)
 ;;=M92.72^^139^1991^12
 ;;^UTILITY(U,$J,358.3,47686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47686,1,3,0)
 ;;=3^Juvenile osteochondrosis of metatarsus, lft ft
 ;;^UTILITY(U,$J,358.3,47686,1,4,0)
 ;;=4^M92.72
 ;;^UTILITY(U,$J,358.3,47686,2)
 ;;=^5015240
 ;;^UTILITY(U,$J,358.3,47687,0)
 ;;=M92.62^^139^1991^13
 ;;^UTILITY(U,$J,358.3,47687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47687,1,3,0)
 ;;=3^Juvenile osteochondrosis of tarsus, lft ankl
 ;;^UTILITY(U,$J,358.3,47687,1,4,0)
 ;;=4^M92.62
 ;;^UTILITY(U,$J,358.3,47687,2)
 ;;=^5015237
 ;;^UTILITY(U,$J,358.3,47688,0)
 ;;=M92.61^^139^1991^14
 ;;^UTILITY(U,$J,358.3,47688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47688,1,3,0)
 ;;=3^Juvenile osteochondrosis of tarsus, rt ankle
 ;;^UTILITY(U,$J,358.3,47688,1,4,0)
 ;;=4^M92.61
 ;;^UTILITY(U,$J,358.3,47688,2)
 ;;=^5015236
 ;;^UTILITY(U,$J,358.3,47689,0)
 ;;=Z47.89^^139^1991^16
 ;;^UTILITY(U,$J,358.3,47689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47689,1,3,0)
 ;;=3^Orthopedic aftercare, oth
 ;;^UTILITY(U,$J,358.3,47689,1,4,0)
 ;;=4^Z47.89
 ;;^UTILITY(U,$J,358.3,47689,2)
 ;;=^5063032
 ;;^UTILITY(U,$J,358.3,47690,0)
 ;;=M19.072^^139^1991^18
 ;;^UTILITY(U,$J,358.3,47690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47690,1,3,0)
 ;;=3^Osteoarthritis,Left Ankle/Foot,Primary
 ;;^UTILITY(U,$J,358.3,47690,1,4,0)
 ;;=4^M19.072
 ;;^UTILITY(U,$J,358.3,47690,2)
 ;;=^5010821
 ;;^UTILITY(U,$J,358.3,47691,0)
 ;;=M19.071^^139^1991^19
 ;;^UTILITY(U,$J,358.3,47691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47691,1,3,0)
 ;;=3^Osteoarthritis,Right Ankle/Foot,Primary
 ;;^UTILITY(U,$J,358.3,47691,1,4,0)
 ;;=4^M19.071
 ;;^UTILITY(U,$J,358.3,47691,2)
 ;;=^5010820
 ;;^UTILITY(U,$J,358.3,47692,0)
 ;;=M19.90^^139^1991^20
 ;;^UTILITY(U,$J,358.3,47692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47692,1,3,0)
 ;;=3^Osteoarthritis,Unspec Site
 ;;^UTILITY(U,$J,358.3,47692,1,4,0)
 ;;=4^M19.90
 ;;^UTILITY(U,$J,358.3,47692,2)
 ;;=^5010853
 ;;^UTILITY(U,$J,358.3,47693,0)
 ;;=M96.0^^139^1992^14
 ;;^UTILITY(U,$J,358.3,47693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47693,1,3,0)
 ;;=3^Pseudarthrosis after fusion or arthrodesis
 ;;^UTILITY(U,$J,358.3,47693,1,4,0)
 ;;=4^M96.0
 ;;^UTILITY(U,$J,358.3,47693,2)
 ;;=^5015373
 ;;^UTILITY(U,$J,358.3,47694,0)
 ;;=R20.2^^139^1992^1
 ;;^UTILITY(U,$J,358.3,47694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47694,1,3,0)
 ;;=3^Paresthesia of skin
 ;;^UTILITY(U,$J,358.3,47694,1,4,0)
 ;;=4^R20.2
 ;;^UTILITY(U,$J,358.3,47694,2)
 ;;=^5019280
 ;;^UTILITY(U,$J,358.3,47695,0)
 ;;=I87.003^^139^1992^12
 ;;^UTILITY(U,$J,358.3,47695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47695,1,3,0)
 ;;=3^Postthrom syndr w/o compl of bilat lwr extrem
 ;;^UTILITY(U,$J,358.3,47695,1,4,0)
 ;;=4^I87.003
 ;;^UTILITY(U,$J,358.3,47695,2)
 ;;=^5008029
 ;;^UTILITY(U,$J,358.3,47696,0)
 ;;=I87.001^^139^1992^11
 ;;^UTILITY(U,$J,358.3,47696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47696,1,3,0)
 ;;=3^Postrhomb syndr w/o compl of rt lwr extrem
 ;;^UTILITY(U,$J,358.3,47696,1,4,0)
 ;;=4^I87.001
 ;;^UTILITY(U,$J,358.3,47696,2)
 ;;=^5008027
 ;;^UTILITY(U,$J,358.3,47697,0)
 ;;=I80.01^^139^1992^8
 ;;^UTILITY(U,$J,358.3,47697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47697,1,3,0)
 ;;=3^Phlebitis & Thromboph,Right Lower Sprfcl Vessels
 ;;^UTILITY(U,$J,358.3,47697,1,4,0)
 ;;=4^I80.01
 ;;^UTILITY(U,$J,358.3,47697,2)
 ;;=^5007821
 ;;^UTILITY(U,$J,358.3,47698,0)
 ;;=I80.02^^139^1992^6
 ;;^UTILITY(U,$J,358.3,47698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47698,1,3,0)
 ;;=3^Phlebitis & Thromboph,Left Lower Sprfcl Vessels
 ;;^UTILITY(U,$J,358.3,47698,1,4,0)
 ;;=4^I80.02
 ;;^UTILITY(U,$J,358.3,47698,2)
 ;;=^5007822
 ;;^UTILITY(U,$J,358.3,47699,0)
 ;;=I80.03^^139^1992^4
 ;;^UTILITY(U,$J,358.3,47699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47699,1,3,0)
 ;;=3^Phlebitis & Thromboph,Bilateral Lower Sprfcl Vessels
 ;;^UTILITY(U,$J,358.3,47699,1,4,0)
 ;;=4^I80.03
 ;;^UTILITY(U,$J,358.3,47699,2)
 ;;=^5007823
 ;;^UTILITY(U,$J,358.3,47700,0)
 ;;=I80.11^^139^1992^7
 ;;^UTILITY(U,$J,358.3,47700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47700,1,3,0)
 ;;=3^Phlebitis & Thromboph,Right Femoral Vein
 ;;^UTILITY(U,$J,358.3,47700,1,4,0)
 ;;=4^I80.11
 ;;^UTILITY(U,$J,358.3,47700,2)
 ;;=^5007825
 ;;^UTILITY(U,$J,358.3,47701,0)
 ;;=I80.12^^139^1992^5
 ;;^UTILITY(U,$J,358.3,47701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47701,1,3,0)
 ;;=3^Phlebitis & Thromboph,Left Femoral Vein
 ;;^UTILITY(U,$J,358.3,47701,1,4,0)
 ;;=4^I80.12
 ;;^UTILITY(U,$J,358.3,47701,2)
 ;;=^5007826
 ;;^UTILITY(U,$J,358.3,47702,0)
 ;;=I80.13^^139^1992^3
 ;;^UTILITY(U,$J,358.3,47702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47702,1,3,0)
 ;;=3^Phlebitis & Thromboph,Bilateral Femora Vein
 ;;^UTILITY(U,$J,358.3,47702,1,4,0)
 ;;=4^I80.13
 ;;^UTILITY(U,$J,358.3,47702,2)
 ;;=^5007827
 ;;^UTILITY(U,$J,358.3,47703,0)
 ;;=L98.0^^139^1992^21
 ;;^UTILITY(U,$J,358.3,47703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47703,1,3,0)
 ;;=3^Pyogenic granuloma
 ;;^UTILITY(U,$J,358.3,47703,1,4,0)
 ;;=4^L98.0
 ;;^UTILITY(U,$J,358.3,47703,2)
 ;;=^5009574
 ;;^UTILITY(U,$J,358.3,47704,0)
 ;;=L40.0^^139^1992^16
 ;;^UTILITY(U,$J,358.3,47704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47704,1,3,0)
 ;;=3^Psoriasis vulgaris
 ;;^UTILITY(U,$J,358.3,47704,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,47704,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,47705,0)
 ;;=L40.1^^139^1992^19
 ;;^UTILITY(U,$J,358.3,47705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47705,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,47705,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,47705,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,47706,0)
 ;;=L40.9^^139^1992^17
 ;;^UTILITY(U,$J,358.3,47706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47706,1,3,0)
 ;;=3^Psoriasis, unspec
 ;;^UTILITY(U,$J,358.3,47706,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,47706,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,47707,0)
 ;;=L40.3^^139^1992^20
 ;;^UTILITY(U,$J,358.3,47707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47707,1,3,0)
 ;;=3^Pustulosis palmaris et plantaris
